Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ACS chemical neuroscience molecule spotlight on latuda (lurasidone; SM-13,496).

× No keyword cloud information.

4 in total

1. The economic burden of schizophrenia in the United States in 2002.

Authors: Eric Q Wu; Howard G Birnbaum; Lizheng Shi; Daniel E Ball; Ronald C Kessler; Matthew Moulis; Jyoti Aggarwal
Journal: J Clin Psychiatry Date: 2005-09 Impact factor: 4.384

2. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.

Authors: Tadashi Ishibashi; Tomoko Horisawa; Kumiko Tokuda; Takeo Ishiyama; Masaaki Ogasa; Rie Tagashira; Kenji Matsumoto; Hiroyuki Nishikawa; Yoko Ueda; Satoko Toma; Hitomi Oki; Norihiko Tanno; Ikutaro Saji; Akira Ito; Yukihiro Ohno; Mitsutaka Nakamura
Journal: J Pharmacol Exp Ther Date: 2010-04-19 Impact factor: 4.030

3. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.

Authors: Mitsutaka Nakamura; Masaaki Ogasa; John Guarino; Debra Phillips; Joseph Severs; Josephine Cucchiaro; Antony Loebel
Journal: J Clin Psychiatry Date: 2009-06-02 Impact factor: 4.384

4. Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test.

Authors: Takeo Ishiyama; Kumiko Tokuda; Tadashi Ishibashi; Akira Ito; Satoko Toma; Yukihiro Ohno
Journal: Eur J Pharmacol Date: 2007-07-10 Impact factor: 4.432

4 in total

1 in total

Review 1. Lurasidone : in the treatment of schizophrenia.

Authors: Mark Sanford
Journal: CNS Drugs Date: 2013-01 Impact factor: 5.749

1 in total